T cell receptor beta variable 6-6 (TRBV6-6)

T cell receptor beta variable 6-6 (TRBV6-6) is a gene encoding the variable region of the beta chain of the T cell receptor (TCR) complex[1]. This region is crucial for the recognition of antigenic peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells, enabling T lymphocytes to distinguish between self and non-self antigens and launch adaptive immune responses[1][3][5]. The TRBV6-6 gene is part of the highly diverse *TRBV* locus, which undergoes somatic V(D)J recombination during T cell development to generate a broad repertoire of TCRs, critical for immune surveillance[1][3]. Polymorphisms in TRBV6-6 and related TRBV genes have been associated with susceptibility to autoimmune diseases and differential risk for immune-related adverse events (irAEs), especially during immune checkpoint inhibitor therapies for cancer[4][6]. The gene product is an integral plasma membrane protein functioning as part of the TCR complex, and acts as a primary sensor triggering T cell activation and downstream signaling pathways leading to T-cell effector functions[1][3]. There are currently no specific drugs known to directly target individual TRBV gene products, such as TRBV6-6; rather, the broader TCR pathway and repertoire are relevant as biomarkers and mechanistic determinants in immunotherapies and autoimmunity[4][6].

Other names

TRBV6-6TRBV66TCRBV13S6A2TTCRBV6S6V segment translation product